Literature DB >> 31178204

Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence.

Woo Ri Choi1, Jong-Lyel Roh2, Gyungyup Gong3, Kyung-Ja Cho3, Seung-Ho Choi1, Soon Yuhl Nam1, Sang Yoon Kim1.   

Abstract

OBJECTIVES: Tumor multifocality or bilaterality is associated with increased risk of papillary thyroid carcinoma (PTC) recurrence. However, its prognostic value in clinical outcomes remains controversial. This study aimed to evaluate the association of multifocality or bilaterality with recurrence and survival after total thyroidectomy.
METHODS: This was a retrospective study of 2390 consecutive patients with pathologically confirmed PTC who underwent total thyroidectomy. Multifocality and bilaterality were decided based on the final pathology results, that is, if there were two or more tumor foci and bilateral location, respectively. Primary outcomes were recurrence-free survival (RFS). Cox proportional hazards regression analyses were used to assess the associations of multifocality, bilaterality, and other clinicopathological factors with RFS.
RESULTS: Multifocal and bilateral PTC were found in 892 (37.3%) and 593 (24.8%) patients, respectively. Multivariate analyses showed that multifocality, lymphovascular invasion, N category, and number of positive lymph node (>5) were significant independent variables predictive of RFS (all P < 0.05). Multifocality was associated with adjusted hazard ratios for RFS of 1.93 (95% confidence interval = 1.33-2.80; P = 0.001). In a subset analysis, the prognostic value of multifocality was found to be significant in those patients with PTC > 1 cm, but not in papillary thyroid microcarcinoma.
CONCLUSIONS: Tumor multifocality is an independent risk factor of PTC recurrence after total thyroidectomy. This indicate a more progressive state of disease, being included in risk stratification.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bilaterality; Multifocality; Papillary thyroid carcinoma; Recurrence; Risk factor

Mesh:

Year:  2019        PMID: 31178204     DOI: 10.1016/j.oraloncology.2019.05.023

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  15 in total

1.  Predicting factors of central lymph node metastases in patients with unilateral multifocal papillary thyroid microcarcinoma.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng; Xiaodong He
Journal:  Gland Surg       Date:  2020-06

2.  Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden.

Authors:  Jacopo Manso; Simona Censi; Amir Roberti; Maurizio Iacobone; Susi Barollo; Loris Bertazza; Francesca Galuppini; Federica Vianello; Nora Albinger; Carla Scaroni; Gianmaria Pennelli; Caterina Mian
Journal:  Ther Adv Endocrinol Metab       Date:  2020-10-12       Impact factor: 3.565

3.  Long-term outcomes and prognostic factors in papillary thyroid microcarcinoma patients with distant metastases.

Authors:  Huai-Yu Weng; Ting Yan; Wang-Wang Qiu; Chuang Xi; Li-Ying Hou; Zhi-Li Yang; Zhong-Ling Qiu
Journal:  Endocrine       Date:  2021-10-26       Impact factor: 3.633

4.  Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Jingxin Mao; Qinghai Zhang; Haiyan Zhang; Ke Zheng; Rui Wang; Guoze Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-15       Impact factor: 5.555

5.  Predictive Factors of Recurrence in Patients with Differentiated Thyroid Carcinoma: A Retrospective Analysis on 579 Patients.

Authors:  Fabio Medas; Gian Luigi Canu; Francesco Boi; Maria Letizia Lai; Enrico Erdas; Pietro Giorgio Calò
Journal:  Cancers (Basel)       Date:  2019-08-22       Impact factor: 6.639

6.  Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.

Authors:  Jia-Wei Feng; Jing Ye; Wan-Xiao Wu; Hua Pan; An-Cheng Qin; Yong Jiang; Bao-Qiang Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-08       Impact factor: 5.555

7.  Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.

Authors:  Yijie Huang; Ying Yin; Wenyi Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-05       Impact factor: 5.555

8.  With High-Risk Factors, Total Thyroidectomy is Preferred for Thyroid Cancer.

Authors:  Lin Han; Wenlei Li; Yingxue Li; Wenjuan Wen; Yumin Yao; Yongkun Wang
Journal:  Cancer Manag Res       Date:  2020-05-20       Impact factor: 3.989

9.  Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.

Authors:  Lin Yan; Mingbo Zhang; Qing Song; Fang Xie; Yukun Luo
Journal:  Eur Radiol       Date:  2021-08-06       Impact factor: 5.315

10.  The Efficacy and Safety of Radiofrequency Ablation for Bilateral Papillary Thyroid Microcarcinoma.

Authors:  Lin Yan; Mingbo Zhang; Qing Song; Jing Xiao; Ying Zhang; Yukun Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.